This business information is not released now.


Back
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.


Jitsubo CO., LTD.
【Field/Business】
Drug discovery support/Contract service
Pharmaceutical/Drug Discovery

last update:2017/9/14
Profile

Delegates :
Teruaki Tsukamoto


Incorporated :
April  8 , 2005

Paid in Capital :
100 Million yen  

Employees :
22 人

Address :
Life Science Research Center 4-1 1-1-43, Suehiro-cho, Tsurumi, Yokohama KANAGAWA
〒230-0045

TEL/FAX :
+81-45-633-4327 / +81-45-633-4329

URL:
http://www.jitsubo.com

Attachment :

Mission/Background :
Jitsubo is a privately-held biopharmaceutical company, employing our proprietary Molecular Hiving and Peptune platform for the discovery and development of new peptide-based drugs.

Molecular Hiving is a new generation peptide manufacturing technology enabling to provide the peptide drug substances in a sufficient quality and cost with short lead time.
By utilizing Peptune technology, peptides receive better therapeutic property. This technology also enables multi-functionalization of the peptide such as attaching targeting material with no loss of expected original efficacy.

Jitsubo creates a new value for peptide based drugs with process and product innovation.

Technology & Business
Molecular Hiving is a new liquid phase based peptide synthesis technology using hydrophobic tag. This technology integrates the advantages of both liquid phase method and solid phase method and made it good hybrid.

Peptune is a new type of chemical engineering technology introducing artificial bridge into peptides. This technology provides derivatives with a vast of steric constraint and conjugates with other functional moiety on bridge head position. The unprecedented chemical capability contributes rapid and efficient optimization of therapeutic property.
Products & Service
Products & Service Name
Stage
Outline
Milestone
Co-development of peptide generic products
Others
Jitsubo looks for a pharmaceutical company to commercialize the peptide generic drugs under development in-house.
Finding a partner for Jitsubo's candidate products
Co-development of alternative administration products
Others
Jitsubo looks for a collaboration opportunity with delivery tech. co. to develop high compliance products.
Finding a partner for Jitsubo's candidate products
Technology licensing
Others
Jitsubo looks for out-licensing opportunity of Molecular Hiving.









Highlights
Jitsbo is promoting research collaboration with Heptares Therapeutics (UK) to develop novel peptide candidates designed to target a G protein-coupled receptor implicated in severe gastro-intestinal disorders.
Hot news

Alliance strategy
1. Co-develop and licensing the peptide generic products or DS
2. Co-develop 505(b)(2) products with non-invasive administration
3. Licensing the MH technology based on your drug substances



 
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.